Cyclic AMP formation and release by cultured bone cells stimulated with prostaglandin E2.
PGE2 produced a marked and dose-related increase in cAMP content of cultured bone cells and in the release of cAMP into the incubation medium. The amount of cAMP released from the cells by PGE2 was proportional to the cellular concentration, and was dependent upon the time of incubation with PGE2. The cAMP levels released into the media increased slowly at a linear rate during a 60 min treatment with PGE2. This release was blocked by theophylline, probenecid, ouabain and dinitrophenol, suggesting that the release of cAMP was not a simple diffusive process and required energy. SC-19220 reduced the formation of cAMP more than the release, suggesting that the formation and the release may arise from separate events. Inability of D600 to inhibit PGE2-induced release of cAMP indicates that the release does not require calcium.
D000818:Animals; D001842:Bone and Bones / Q000166:cytology / Q000378:metabolism*; D002478:Cells, Cultured; D003470:Culture Media; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000378:metabolism; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005711:Gallopamil / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D011458:Prostaglandins E / Q000008:administration & dosage / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D003470:Culture Media; D004140:Dinitrophenols; D011458:Prostaglandins E; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; D005711:Gallopamil; D010042:Ouabain; D013806:Theophylline; D000242:Cyclic AMP; D011339:Probenecid